Featured Publications
Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease
Leeds IL, Sklow B, Gorgun E, Liska D, Lightner AL, Hull TL, Steele SR, Holubar SD. Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease. Journal Of Gastrointestinal Surgery 2022, 26: 1275-1285. PMID: 35277799, DOI: 10.1007/s11605-022-05287-z.Peer-Reviewed Original ResearchConceptsInflammatory bowel disease surgeryLow-dose aspirinQuality-adjusted life yearsThromboembolism prophylaxisDisease surgeryUnfavorable incremental cost-effectiveness ratiosLife yearsExtended venous thromboembolism prophylaxisPost-discharge event ratePocket costsIncremental cost-effectiveness ratioVenous thromboembolism prophylaxisEfficacy of aspirinInflammatory bowel diseaseMedian hospital costsMonte Carlo probabilistic sensitivity analysisCost-effectiveness ratioProbabilistic sensitivity analysesDecision analysis modelEnoxaparin regimenThromboembolism ratesVenous thromboembolismBowel diseaseColorectal surgeryCase patients
2020
Cost-utility of colorectal cancer screening at 40 years old for average-risk patients
Azad NS, Leeds IL, Wanjau W, Shin EJ, Padula WV. Cost-utility of colorectal cancer screening at 40 years old for average-risk patients. Preventive Medicine 2020, 133: 106003. PMID: 32001308, PMCID: PMC8710143, DOI: 10.1016/j.ypmed.2020.106003.Peer-Reviewed Original ResearchQuality-adjusted life yearsMultivariable probabilistic sensitivity analysesNet monetary benefitIncremental cost-utility ratioLimited societal perspectiveCost-utility ratioProbabilistic sensitivity analysesMonetary benefitsSocietal perspectiveLife yearsAvailable screening modalitiesFavorable interventionWillingnessSensitivity analysisPayStandard screeningCost
2018
Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults
Leeds IL, Namasivayam V, Bamogo A, Sankhla P, Thayer WM. Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults. American Journal Of Preventive Medicine 2018, 56: 196-204. PMID: 30573332, PMCID: PMC6340776, DOI: 10.1016/j.amepre.2018.09.020.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsMultivariable probabilistic sensitivity analysesUniversal vaccinationProbabilistic sensitivity analysesLife yearsSerogroup BSocietal perspectiveYoung adultsHealth sector perspectiveUniversal vaccination strategyNeisseria meningitidis serogroup BN. meningitidis serogroup BCost effectivenessU.S. vaccineB vaccinationMeningococcal infectionVaccination strategiesSpecific vaccinesVaccinationSensitivity analysisIncremental costOutbreak responseSector perspectiveCollege entryCommon form